Preventive Administration of Melatonin Attenuates Electrophysiological Consequences of Myocardial Ischemia

Bull Exp Biol Med. 2020 Jul;169(3):328-331. doi: 10.1007/s10517-020-04881-y. Epub 2020 Aug 3.

Abstract

The effect of preventive administration of melatonin on the arrhythmogenic substrate in the myocardium was studied in the rabbit model of acute ischemia/reperfusion in vivo. The animals treated with melatonin 60 min before ischemia induction had shorter median activation time compared to the control group (p=0.039), less pronounced shortening of repolarization durations in the ischemic zone during coronary occlusion (p=0.008), and more complete recovery of repolarization during reperfusion (p=0.027). In the melatonin group, the dispersion of repolarization was less than in the control group during both ischemic period (p=0.043) and reperfusion (p=0.038). Thus, preventive administration of melatonin mitigated the arrhythmogenic substrate in the heart under conditions of ischemia/reperfusion.

Keywords: dispersion of repolarization; ischemia/reperfusion; melatonin.

MeSH terms

  • Animals
  • Cardiac Electrophysiology
  • Heart / physiology
  • Male
  • Melatonin / therapeutic use*
  • Myocardial Ischemia / drug therapy*
  • Myocardial Ischemia / physiopathology*
  • Myocardial Reperfusion Injury / drug therapy*
  • Myocardial Reperfusion Injury / physiopathology*
  • Rabbits

Substances

  • Melatonin